Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metal-Ligand Bonds02:51

Metal-Ligand Bonds

The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
Complexation Equilibria: The Chelate Effect01:19

Complexation Equilibria: The Chelate Effect

In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of cannabinoids.

The lancet. Psychiatry·2026
Same author

Trends and disparities in self-reported past-month poor mental health among individuals using cannabis in the U.S., 2016-2023.

Social psychiatry and psychiatric epidemiology·2026
Same author

Integrated Proteomics and Metabolomics Analysis Reveals Potential Pathways Underlying Onion-Mediated Regulation of Spleen Immune Function in Liangshan Black Sheep.

Veterinary sciences·2026
Same author

Toxicology-informed sequencing to optimise cancer therapy.

Lancet (London, England)·2026
Same author

Which Nudges Matter Most for Scalable Influenza Vaccination?

JAMA internal medicine·2026
Same author

Digital measurement and safety parameter analysis of the infra-acetabular screw pathway.

BMC surgery·2026

Related Experiment Video

Updated: Jun 25, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Ligand-based neutral ruthenium(II) arene complex: selective anticancer action.

Chun-Hui Wu1, De-Hong Wu, Xuan Liu

  • 1State Key Laboratory of Bioelectronics (Chien-Shiung Wu Laboratory), Southeast University, Nanjing, Jiangsu 210096, China.

Inorganic Chemistry
|February 18, 2009
PubMed
Summary

Two new ruthenium(II) arene complexes with carborane units were synthesized and tested for anticancer activity. Modifying the ligand structure enhanced selectivity and inhibited cancer cell proliferation, highlighting the importance of ligand tuning for developing targeted cancer therapies.

More Related Videos

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
10:51

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Related Experiment Videos

Last Updated: Jun 25, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
10:51

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Area of Science:

  • Organometallic Chemistry
  • Medicinal Chemistry
  • Cancer Research

Background:

  • Ruthenium(II) arene complexes are investigated for their therapeutic potential.
  • Carborane-containing compounds offer unique properties for drug development.
  • Selective inhibition of cancer cell proliferation remains a critical challenge in oncology.

Purpose of the Study:

  • To synthesize novel ruthenium(II) arene complexes incorporating a carborane unit.
  • To evaluate the cytostatic effects of these complexes on cancerous cells.
  • To understand how structural modifications influence selectivity and efficacy against cancer.

Main Methods:

  • Synthesis of two new ruthenium(II) arene complexes, denoted 2a and 2b.
  • Evaluation of the cytostatic activity of the synthesized complexes.
  • Comparative analysis of structural variations (ferrocene vs. carboxyl group) and their impact on biological activity.

Main Results:

  • The synthesized complexes, 2a and 2b, demonstrated cytostatic effects on cancerous cells.
  • A structural modification from a ferrocene unit to a carboxyl group resulted in high selectivity toward cancer cells.
  • Efficient inhibition of target cancer cell proliferation was observed with the modified complex.

Conclusions:

  • Ligand tuning in ruthenium(II) arene complexes is crucial for developing selective antineoplastic agents.
  • Structural modifications can significantly enhance the selectivity and efficacy of ruthenium-based anticancer drugs.
  • The carboxyl group-containing complex shows promise as a targeted therapeutic agent for cancer.